Angiotensin inhibition enhances drug delivery and potentiates chemotherapy by decompressing tumour blood vessels
Open accessThe DOI matches its Crossref record; 64 of the 64 references it cites were found in a registry or an index.
Abstract
Cancer and stromal cells actively exert physical forces (solid stress) to compress tumour blood vessels, thus reducing vascular perfusion. Tumour interstitial matrix also contributes to solid stress, with hyaluronan implicated as the primary matrix molecule responsible for vessel compression because of its swelling behaviour. Here we show, unexpectedly, that hyaluronan compresses vessels only in collagen-rich tumours, suggesting that collagen and hyaluronan together are critical targets for decompressing tumour vessels. We demonstrate that the angiotensin inhibitor losartan reduces stromal collagen and hyaluronan production, associated with decreased expression of profibrotic signals TGF-β1, CCN2 and ET-1, downstream of angiotensin-II-receptor-1 inhibition. Consequently, losartan reduces solid stress in tumours resulting in increased vascular perfusion. Through this physical mechanism, losartan improves drug and oxygen delivery to tumours, thereby potentiating chemotherapy and reducing hypoxia in breast and pancreatic cancer models. Thus, angiotensin inhibitors —inexpensive drugs with decades of safe use — could be rapidly repurposed as cancer therapeutics. Hyaluronan is a component of the tumour extracellular matrix. Here, Chauhan et al. show that hyaluronan increases blood pressure in collagen-rich tumours by compressing vessel walls, and that reducing the level of hyaluranon with an angiotensin II inhibitor increases blood flow and drug penetrance in tumours.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures







Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Therefore, antiangiogenic drugs have a synergistic antitumor effect in combination with radiotherapy and chemotherapy in clinical practice.”
From Hypoxia signaling in cancer: Implications for therapeutic interventions (2023) · cites this paper as [260]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Increased mechanical stress can collapse blood vessels, leading to hypoxia, thereby promoting more aggressive cancer phenotypes, and reducing drug delivery89,100–105.”
From A framework for advancing our understanding of cancer-associated fibroblasts (2020) · cites this paper as [101]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“We have also shown that widely prescribed ARBs can normalize the stroma and decompress blood vessels, thereby improving the outcome of chemotherapy94.”
From Enhancing cancer immunotherapy using antiangiogenics: opportunities and challenges (2018) · cites this paper as [94]
In the citing paper
“results from our laboratory have shown that the elevated levels of extracellular matrix molecules, including collagen I and hyaluronan, in such tumours can compress blood vessels, impairing their function and resulting in hypoxia94.”
From Enhancing cancer immunotherapy using antiangiogenics: opportunities and challenges (2018) · cites this paper as [94]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Provenzano, P. P., Cuevas, C., Chang, A. E., Goel, V. K., Von Hoff, D. D., & Hingorani, S. R. (2012) · Cancer Cell · doi:10.1016/j.ccr.2012.01.007 · Cited by 2,195 · cited 1×
“Hyaluronan has been proposed to be the primary matrix molecule responsible for vessel compression 12 , but its exact mechanism remains unclear.”
Losartan, an AT1 Antagonist, Prevents Aortic Aneurysm in a Mouse Model of Marfan Syndrome
Habashi, J. P., Judge, D. P., Holm, T. M., Cohn, R. D., Loeys, B. L., Cooper, T. K., Myers, L., Klein, E. C., Liu, G., Calvi, C., et al. (2006) · Science · doi:10.1126/science.1124287 · Cited by 1,794
DeNardo, D. G., Brennan, D. J., Rexhepaj, E., Ruffell, B., Shiao, S. L., Madden, S. F., Gallagher, W. M., Wadhwani, N., Keil, S. D., Junaid, S. A., et al. (2011) · Cancer Discovery · doi:10.1158/2159-8274.cd-10-0028 · Cited by 1,715 · cited 1×
“This might be attributed to resistance induced by the immune microenvironment 39 .”
Helmlinger, G., Yuan, F., Dellian, M., & Jain, R. K. (1997) · Nature Medicine · doi:10.1038/nm0297-177 · Cited by 1,628 · cited 2×
“We then studied oxygenation using phosphorescence quenching microscopy 35 .”
Self-citationNormalizing Tumor Microenvironment to Treat Cancer: Bench to Bedside to Biomarkers
Jain, R. K. (2013) · Journal of Clinical Oncology · doi:10.1200/jco.2012.46.3653 · Cited by 1,248 · cited 2×
“…data notwithstanding, it should be noted that antiangiogenic therapy with bevacizumab has failed to prolong survival in desmoplastic tumours such as breast and pancreatic cancer 3 , casting doubt on a possible antiangiogenic mechanism for the benefits observed with angiotensin inhibitors.”
Self-citationChauhan, V. P., Stylianopoulos, T., Martin, J. D., Popović, Z., Chen, O., Kamoun, W. S., Bawendi, M. G., Fukumura, D., & Jain, R. K. (2012) · Nature Nanotechnology · doi:10.1038/nnano.2012.45 · Cited by 1,101
Self-citationCauses, consequences, and remedies for growth-induced solid stress in murine and human tumors
Stylianopoulos, T., Martin, J. D., Chauhan, V. P., Jain, S. R., Diop-Frimpong, B., Bardeesy, N., Smith, B. L., Ferrone, C. R., Hornicek, F. J., Boucher, Y., et al. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1213353109 · Cited by 943 · cited 6×
“Both hyaluronan and collagen fibres contribute to solid stress in tumours: hyaluronan does so by resisting compression, whereas collagen does so by resisting tension and confining the local microenvironment 5 .”
InfluentialSelf-citationSolid stress inhibits the growth of multicellular tumor spheroids
Helmlinger, G., Netti, P. A., Lichtenbeld, H. C., Melder, R. J., & Jain, R. K. (1997) · Nature Biotechnology · doi:10.1038/nbt0897-778 · Cited by 859 · cited 1×
“Solid stress (pressure from solid tissue components) accumulates in tumours as cancer and stromal cells proliferate in a confined microenvironment created by crosslinked matrix molecules 4–6 .”
Self-citationEffects on blood pressure and exploratory behaviour of mice lacking angiotensin II type-2 receptor
Ichiki, T., Labosky, P. A., Shiota, C., Okuyama, S., Imagawa, Y., Fogo, A., Niimura, F., Ichikawa, I., Hogan, B. L. M., & lnagami, T. (1995) · Nature · doi:10.1038/377748a0 · Cited by 858
Cancer cells compress intratumour vessels
Padera, T. P., Stoll, B. R., Tooredman, J. B., Capen, D., Tomaso, E. D., & Jain, R. K. (2004) · Nature · doi:10.1038/427695a · Cited by 857 · cited 2×
“The matrix stores and transmits this stress throughout the tumour 7 , collapsing blood vessels to limit perfusion 8,9 .”
Self-citation
Cited by
Items 901–1,000 of 1,000
Yin, J., Dong, F., An, J., Zhang, J., & Zhang, J. (2023) · IEEE International Ultrasonics Symposium · doi:10.1109/ius51837.2023.10307466 · Cited by 1
“The presence of significant variation within the tumor microenvironment may indicate that the aggressive behavior of the tumor is linked to its highly heterogenous lesions[2, 4, 5].”
BackgroundPijeira, M. S. O. (2019) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/t.85.2019.tde-10062019-095737 · Cited by 1
Chan, W., & Tseng, F. (2021) · Nanomedicine · doi:10.2217/nnm-2021-0082 · Cited by 1
Li, C., Maishi, N., Annan, D. A., Young, M. F., Morimoto, H., Morimoto, M., Nam, J.-M., Hida, Y., & Hida, K. (2021) · Research Square · doi:10.21203/rs.3.rs-142861/v1 · Cited by 1
Letter to the editor regarding recent article by Wu et al. [J. Theor. Biol. 355 (2014) pp. 194–207]
Jain, R. K., & Netti, P. A. (2014) · Journal of Theoretical Biology · doi:10.1016/j.jtbi.2014.08.052
Self-citationTargeting the Tumor Stroma in Breast Cancer
Sánchez-Ruíz, J., & Quintela-Fandiño, M. (2015) · Current Breast Cancer Reports · doi:10.1007/s12609-014-0173-9
Ciblage thérapeutique du microenvironnement tumoral : exemple du cancer du pancréas
Samain, R. (2014) · OpenGrey (Institut de l'Information Scientifique et Technique) · Cited by 1
Effects of vascularization on cancer nanochemotherapy outcomes
Paiva, L. R., Ferreira, S. C., & Martins, M. L. (2016) · Physica A Statistical Mechanics and its Applications · doi:10.1016/j.physa.2016.02.065
Congrès de l’association américaine de recherche contre le cancer — AACR 2016
Vicier, C., Guillebon, É. D., Kieffer, A., Turpin, A., Dumont, C., Bellesœur, A., Soares, D. G., & Lotz, J. (2016) · ONCOLOGIE · doi:10.1007/s10269-016-2647-z
Quoi de neuf en recherche fondamentale et translationnelle sur le cancer du pancréas ?
Buscail, L., & Bournet, B. (2015) · ONCOLOGIE · doi:10.1007/s10269-015-2569-1
Leonard, F., & Godin, B. (2016) · Fundamental biomedical technologies · doi:10.1007/978-3-319-43525-1_4 · Cited by 1
Tyson, R., Osae, L., Madden, A. J., Lucas, A. T., & Zamboni, W. C. (2016) · Wiley eBooks · doi:10.1002/9783527800681.ch19
Korth, M. (2017) · OPen Access Repositorium der Universität Ulm (OPARU) (Ulm University) · doi:10.18725/oparu-4364
Pogue, B. W., Vincent, P., Xie, R., Gunn, J. R., Nieskoski, M. D., & Marra, K. A. (2018) · Optical Methods for Tumor Treatment and Detection: Mechanisms and Techniques in Photodynamic Therapy · doi:10.1117/12.2309291
Impact du fractionnement de la radiothérapie sur le microenvironnement vasculaire tumoral
Clément-Colmou, K. (2018) · theses.fr (ABES) · doi:10.70675/07822952z3c4az41eaz9ef9z6eeac9686262
Vincent, P., Gunn, J. R., Marra, K. A., Samkoe, K. S., Hoopes, P. J., Hasan, T. G., & Pogue, B. W. (2019) · Optical Methods for Tumor Treatment and Detection: Mechanisms and Techniques in Photodynamic Therapy · doi:10.1117/12.2508796
Stromal and epithelial mechanisms of chemotherapeutic resistance in pancreatic cancer
Patzak, M. S. (2019) · eDiss (Georg-August-Universität Göttingen) · doi:10.53846/goediss-7441
Role of stromal SPARC in PDAC tumorigenesis and drug delivery
Ramu, I. (2019) · eDiss (Georg-August-Universität Göttingen) · doi:10.53846/goediss-7723
Hemodynamic forces control circulating tumor cells dissemination
Follain, G. (2019) · theses.fr (ABES) · doi:10.70675/21fbeeb7zec60z4d52z8434zd8eb3e54cc98
Gemcitabine Resistance Elicits a Calcium Dependent Epigenetic Reprogramming in Pancreatic Cancer
Kutschat, A. P. (2021) · eDiss (Georg-August-Universität Göttingen) · doi:10.53846/goediss-8475
Ak, N. (2021) · Turkish Journal of Oncology · doi:10.5505/tjo.2021.2601
“RASBs may provide synergistic effects with systemic cancer treatment by reducing angiotensin 2-mediated cell proliferation and angiogenesis.[21-23] Although, it lost significance in multivariate analysis, we also found that hypertensive patients using anti-hypertensive drugs showed significantly longer OS (p<0.”
BackgroundOral cancer chemoprevention: COX-2 inhibitor a covenant
Keshwar, S., Grover, S., Shankar, D., & Sarraf, D. P. (2021) · International Journal of Scientific Reports · doi:10.18203/issn.2454-2156.intjscirep20211043
“The tumor growth can compress lymphatics and blood vessels leading to less nutrient and oxygen supply.(18,19) Tobacco smoke can cause cancer as it has the ability to cause chronic inflammation and production of reactive oxygen species (ROS).”
BackgroundBioinformatics Analysis Reveals Biomarkers With Prognostic Benefits in Diffuse Type Gastric CancerPreprint
Li, S., Yu, C., Cheng, Y., Du, F., & Wen, G. (2020) · doi:10.21203/rs.3.rs-36710/v1
“RAS components expressed in many cell types of the tumor microenvironment and directly affected cell proliferation, invasion, migration, metastasis, apoptosis, angiogenesis, cancer-associated in ammation and immunomodulation(26, 27), it could direct or indirect promote tumor growth in many ways, for instance, regulati…”
BackgroundThebaine Derivatives as a New Regulator of Tumor Angiogenesis
Rezaeiamiri, E., Asadi, M., Hosseini, F. S., Amanlou, A., Dehpour, A. R., & Amanlou, M. (2021) · Polycyclic aromatic compounds · doi:10.1080/10406638.2021.1922471
Martins, E. B. (2021) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/d.5.2021.tde-23082021-101842
パリ・オペラ座におけるバレエ音楽の変遷と《ラ・シルフィード》《ジゼル》の誕生
庄子, 未. (2004)
Faculty Opinions recommendation of Physical traits of cancer.
Tanner, K. (2021) · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · doi:10.3410/f.738942894.793586837
Hyaluronan and hyalectans: The good, the bad, and the ugly
Suki, B. (2022) · Elsevier eBooks · doi:10.1016/b978-0-12-819716-5.00013-7
Congrès de l’association américaine de recherche contre le cancer — AACR 2015
Soares, D. G., Michels, J., Hadoux, J., Bellesœur, A., Tlemsani, C., Benderra, M., & Lotz, J. (2015) · ONCOLOGIE · doi:10.1007/s10269-015-2535-y
“giotensine 2 (ARA2), qui entraînent une déplétion en fibres collagènes, améliorent cette perfusion tumorale [75].”
BackgroundKlein, L. (2021) · eDiss (Georg-August-Universität Göttingen) · doi:10.53846/goediss-8402
Timpson, P. (2020) · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · doi:10.3410/f.737260944.793580089
Janmey, P. A. (2019) · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · doi:10.3410/f.735069335.793556332
Sahai, E. A., & Mohammadi, H. (2019) · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · doi:10.3410/f.735069335.793563226
Potential of angiotensin inhibitor as cancer therapeutic
(2013) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2013.189
Calderwood, S. K. (2019) · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · doi:10.3410/f.734959127.793558900
Loi, S. (2019) · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · doi:10.3410/f.732540149.793562857
Nicolas, A. M. (2022) · Publication Server of Goethe University Frankfurt am Main (Goethe University Frankfurt) · doi:10.21248/gups.68107
Extracellular Matrix in Tumor Angiogenesis
Kharaishvili, G. (2022) · IntechOpen eBooks · doi:10.5772/intechopen.104661 · Cited by 1
Nanocarriers-Based Targeted Therapies for Pancreatic Cancer and Challenges Ahead
Sahoo, A., Alam, K., Daniel, S., Beg, S., Kumar, V., Hafeez, A., Rahman, M., & Almalki, W. H. (2022) · Springer eBooks · doi:10.1007/978-981-19-5558-7_7
Role of angiotensin in different malignancies
Kashyap, M. K., Bhat, A., Janjua, D., Rao, R., Thakur, K., Chhokar, A., Aggarwal, N., Yadav, J., Tripathi, T., Chaudhary, A., et al. (2023) · Elsevier eBooks · doi:10.1016/b978-0-323-99618-1.00019-2
Munshi, R., & Maurya, M. R. (2023) · Advances in biochemistry in health and disease · doi:10.1007/978-3-031-23621-1_7
Renin Angiotensin System (RAS): The Common Thread Between Cancer and Heart Failure
Telles-Langdon, S. M., Arya, V., & Jassal, D. S. (2023) · Advances in biochemistry in health and disease · doi:10.1007/978-3-031-23621-1_21 · Cited by 1
Expression of gemcitabine metabolizing enzymes in different pancreatic cancer model systems
Knoll, L. (2023) · eDiss (Georg-August-Universität Göttingen) · doi:10.53846/goediss-9800
Martin, J. D., Lanning, R. M., Chauhan, V. P., Martin, M. R., Mousa, S. M., Kamoun, W. S., Han, H., Lee, H., Stylianopoulos, T., Bawendi, M. G., et al. (2023) · doi:10.1158/1078-0432.c.6532584.v1
Self-citationIncio, J., Liu, H., Suboj, P., Chin, S. M., Chen, I. X., Pinter, M., Ng, M. R., Nia, H. T., Grahovac, J., Kao, S., et al. (2023) · doi:10.1158/2159-8290.22531343
Self-citationDissecting pancreatic cancer tumor-immune microenvironment crosstalk using spatial transcriptomics
Pankaj, A., Mehta, A., Raabe, M. J., Koenig, J. L., Patel, B. K., Lang, E. R., Kocher, J. R., Xu, K. H., Nieman, L. T., Kimmelman, A. C., et al. (2023) · Journal for ImmunoTherapy of Cancer · doi:10.1136/jitc-2023-sitc2023.0655 · Cited by 1
O’Fee, K., Burley, A., & Wilkins, A. C. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-14064-8.00005-9
Panagi, M., Mpekris, F., Voutouri, C., Hadjigeorgiou, A. G., Symeonidou, C., Porfyriou, E., Michael, C., Stylianou, A., Martin, J. D., Cabral, H., et al. (2024) · doi:10.1158/1078-0432.25956526
Self-citationTumor Microenvironment Role in Cancer Immunotherapy Response
Silva, J. C., Xavier, F. C. D. A., & Carrera, M. (2024) · Interdisciplinary cancer research · doi:10.1007/16833_2024_391
O’Fee, K., Burley, A., & Wilkins, A. C. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-14064-8.90005-5
Artamonova, N., Kafka, M., Faiss, L., Avetisyan, D., Sanz, I. P., Bombarda, G. L., Iacono, G., Zattoni, F., Steiner, E., D’Elia, C., et al. (2024) · European Urology Open Science · doi:10.1016/j.euros.2024.09.005
Rôle du compartiment stromal et des macrophages dans le cancer du pancréas
Thierry, K. (2023) · theses.fr (ABES) · doi:10.70675/2d29c373z9920z437fz87e8zee7a50524f26
Gensbittel, V. (2023) · theses.fr (ABES) · doi:10.70675/734ddda3z5fbfz448bz8c22z5dd5a2fa3f7d
Detecting vascular normalization in epithelial ovarian cancer
Mororó, J. D. S., Meira, D. D., Bizzo, S., Altoé, L. S. C., Casotti, M. C., Santana, G. M., Louro, L. S., Louro, T. E. S., Vicente, C. R., de Araújo, B. C., et al. (2025) · Medical Oncology · doi:10.1007/s12032-025-02929-5 · Cited by 2
Schwartz, M. R., Anwar, N. Z., Kitelinger, L. E., Brenin, D. R., Dillon, P. M., Lindner, J. R., Bullock, T. N. J., DeWitt, M. R., & Price, R. J. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.10.23.683708
“To this end, one potential drug class which may be combined with TFUS to improve patient responses to ICIs is angiogenesis inhibitors, which can reverse immunosuppression in the tumor microenvironment, primarily through modulation of tumor vessel properties 32–36 .”
Keith, S. W., Maio, V., Arafat, H. A., Alcusky, M. J., Karagiannis, T., Rabinowitz, C., Lavu, H., & Louis, D. Z. (2022) · Figshare · doi:10.6084/m9.figshare.19136059
Zhou, T., Xie, Y., Hou, X., Bai, W., Li, X., Liu, Z., Man, Q., Sun, J., Fu, D., Yan, J., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26586804
Cong, L., Maishi, N., Annan, D. A., Young, M. F., Morimoto, H., Morimoto, M., Nam, J.-M., Hida, Y., & Hida, K. (2021) · Figshare · doi:10.6084/m9.figshare.14562708
Zhou, T., Xie, Y., Hou, X., Bai, W., Li, X., Liu, Z., Man, Q., Sun, J., Fu, D., Yan, J., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26586798
Cong, L., Maishi, N., Annan, D. A., Young, M. F., Morimoto, H., Morimoto, M., Nam, J.-M., Hida, Y., & Hida, K. (2021) · Figshare · doi:10.6084/m9.figshare.14562711
Zhou, T., Xie, Y., Hou, X., Bai, W., Li, X., Liu, Z., Man, Q., Sun, J., Fu, D., Yan, J., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26586801
Zhou, T., Xie, Y., Hou, X., Bai, W., Li, X., Liu, Z., Man, Q., Sun, J., Fu, D., Yan, J., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26586786
Zhou, T., Xie, Y., Hou, X., Bai, W., Li, X., Liu, Z., Man, Q., Sun, J., Fu, D., Yan, J., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26586792
Zhou, T., Xie, Y., Hou, X., Bai, W., Li, X., Liu, Z., Man, Q., Sun, J., Fu, D., Yan, J., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26586789
Li, W., Li, S., Chen, I. X., Liu, Y., Ramjiawan, R. R., Leung, C.-H., Gerweck, L. E., Fukumura, D., Loeffler, J. S., Jain, R. K., et al. (2021) · Figshare · doi:10.6084/m9.figshare.14167780
Self-citationLi, P.-C., Huang, R.-Y., Yang, Y.-C., Hsieh, K.-P., & Yang, Y.-H. (2022) · Figshare · doi:10.6084/m9.figshare.19625586
Zhou, T., Xie, Y., Hou, X., Bai, W., Li, X., Liu, Z., Man, Q., Sun, J., Fu, D., Yan, J., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26586795
Karjalainen, T. (2025) · Aaltodoc (Aalto University)
Molecular features and clinical significance of cancer-associated fibroblasts in colorectal cancer
Yin, Y., Liu, H., Wu, S., Fu, Y., & Peng, S. (2026) · Molecular Biology of the Cell · doi:10.1091/mbc.e25-10-0476 · Cited by 1
Self-citationMetabolic starvation–induced cell swelling drives solid stress in tumorsPreprint
Dehghany, M., Sharma, V., Annie-Mathew, A. S., Zakharov, A. P., Hu, T., Nader, G. P. F., & Shenoy, V. B. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.02.05.704098
“As a result, strategies that relieve solid stress have shown promise in enhancing treatment efficacy [9-11].”
Mortality Risk in Mucinous Appendiceal Neoplasms: Insights from a National Database
Шерман, С. В., Boualoy, T., Helbing, A. H. B., & Moten, A. S. (2026) · Indian Journal of Surgical Oncology · doi:10.1007/s13193-026-02536-4
An, Y., Wei, P., Zuo, L., Tang, Y., Zhao, Q., Liu, Z., Lang, L., Wang, B., Fan, J., Ma, X., et al. (2026) · Postgraduate Medicine · doi:10.1080/00325481.2026.2633463
“The proliferation of fibrosis can reduce perfusion, impairing the delivery of chemotherapy drugs, to target tissues or tumor cells and reducing the effectiveness of chemotherapy [31,32].”
LIFUS-driven engineered bacteria reprogram immunosuppressive niches via mechano-NOTCH signaling
Lin, L., Li, X., Guo, W., Xie, J., Li, X., Guan, X., Zhao, C., Yin, H., & Xu, H. (2026) · Cell Reports Medicine · doi:10.1016/j.xcrm.2026.102658
“32,33 Building on the functional validation showing a reduction in fibroblast abundance and matrix stiffness within the combined treatment group, we next performed a cell-cell communication analysis to dissect the interactions between CD8 + T cell subsets and fibroblasts.”
Tassano, M. R., & Cabral, P. (2026) · SALUD MILITAR · doi:10.35954/sm2026.45.1.2.e301
Glutamine-dependent changes in fibroblast-derived extracellular matrix dictate cancer cell behavior
Guillard, J., Stradley, J., Turan, K., Storl-Desmond, M., Lin, S. C., Huang, Y.-T., Forti, K. M., Weber, C. R., & Schwörer, S. (2026) · Matrix Biology · doi:10.1016/j.matbio.2026.03.004
Normalization of tumor blood vessels boosted the chemoimmunotherapy of glioblastoma
Gu, Z., Liu, H., Jiang, Z., Zhang, H., Wang, T., Zhang, W., & Li, Z. (2026) · Sustainable materials and technologies · doi:10.1016/j.susmat.2026.e01984 · Cited by 1
Self-citationCamus, M. (2017) · theses.fr (ABES) · doi:10.70675/4def68c4zdc9ez422eza783z692c3f1ea21e
Etude et inhibition de l'activation endothéliale au cours de l'angiogenèse
Cossutta, M. (2017) · theses.fr (ABES) · doi:10.70675/b2ab1c80zb5caz47c4za53bz83c66b494fda · Cited by 1
Li, X., Chang, J., Xia, Q., Yan, J., Zhang, H., & Yang, H. (2026) · Microorganisms · doi:10.3390/microorganisms14040807
“As stress intensifies, it can compress or collapse blood and lymphatic vessels [48–50], inducing hypoxia within the TME [49,51], which compromises the efficacy of chemotherapy, radiotherapy, and immunotherapy [22,52,53].”
Ciblage pharmacologique du microenvironnement de l'adénocarcinome canalaire pancréatique
Samain, R. (2018) · theses.fr (ABES) · doi:10.70675/e35639a1z6534z4cb6z9efbza38473efebed
Bouaouiche, S. (2018) · theses.fr (ABES) · doi:10.70675/85185e48z640cz4823z8ea3z8f24dc88fcdd
Identification of therapeutic targets of nucleolin-related pathways in pancreatic cancer therapy
Raineri, F. (2020) · theses.fr (ABES) · doi:10.70675/b0a30a01z777cz4da7z90cbz3e9a95dd1630
Le rôle des plaquettes dans la formation du microenvironnement tumoral
Chapelain, O. L. (2023) · theses.fr (ABES) · doi:10.70675/cc318f4bz1bdfz42a6za011zd49aa8bf921d
Role of the stromal microenvironment in PDAC and resistance to therapies
Ode, A. (2024) · theses.fr (ABES) · doi:10.70675/0452e0e9z98e8z47d9za007zd4b472926aab
Etude de l'effet du microenvironnement sur le développement de tumeur pancréatique
Coffy, S. (2024) · theses.fr (ABES) · doi:10.70675/bd0a1100zdd28z43d2zb675zdbbcc6dab559
Mierke, C. T. (2026) · Elsevier eBooks · doi:10.1016/b978-0-443-30048-6.00002-4
Metadata
- Authors
- Chauhan, V. P., Martin, J. D., Liu, H., Lacorre, D. A., Jain, S. R., Kozin, S. V., Stylianopoulos, T., Mousa, A. S., Han, X., Adstamongkonkul, P., Popović, Z., Huang, P., Bawendi, M. G., Boucher, Y., & Jain, R. K.
- Affiliations
- Harvard University (US)
- Massachusetts Institute of Technology (US)
- Corresponding author
- Jain, Rakesh K.
- ORCID
- Venue
- Nature Communications
- Published
- 2013-10-01
- Volume
- 4
- Issue
- 1
- Pages
- 2516-2516
- ISSN
- 2041-1723 (ISSN-L)
- PMC
- PMC3806395
- OpenAlex
- W1603491949
- Cited by
- 1,031
- References
- 64
- Citations by year
- 2026: 85 · 2025: 77 · 2024: 86 · 2023: 101 · 2022: 96 · 2021: 128 · 2020: 92 · 2019: 82 · 2018: 66 · 2017: 69 · 2016: 56 · 2015: 54 · 2014: 31 · 2013: 7
- FWCI
- 21.97
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Nature Communications (publishedVersion, cc-by-nc-nd)
- Europe PMC (PubMed Central) (publishedVersion, cc-by-nc-nd)
- PubMed Central (publishedVersion, cc-by-nc-nd)
- PubMed (publishedVersion)
- Digital Access to Scholarship at Harvard (DASH) (Harvard University) (submittedVersion, cc-by)
- RePEc: Research Papers in Economics (submittedVersion)
- DSpace@MIT (Massachusetts Institute of Technology) (submittedVersion, cc-by-nc-nd)
- PMC
- Funders
- U.S. Department of Defense (W81XWH1010016, W81XWH)
- Lustgarten Foundation
- Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology
- National Institutes of Health (1s10rr027070-01, W81XWH, CA080124, CA085140)
- National Cancer Institute (R01CA115767, W81XWH-10-1-0016, T32CA073479, R01CA085140, P01-CA126642, R01-CA11576, P01CA080124, R01CA126642, R01CA098706)
- National Institute of Biomedical Imaging and Bioengineering (P41EB015903)
- National Center for Research Resources (S10-RR027070)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Angiogenesis and VEGF in Cancer
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Cellular Mechanics and Interactions
- Physical Sciences › Mathematics › Modeling and Simulation › Mathematical Biology Tumor Growth
- Keywords
- losartan, hyaluronic acid, tumor stroma, solid stress, collagen, TGF-β1, connective tissue growth factor, endothelin-1, drug delivery, tumor hypoxia, chemotherapy potentiation, breast cancer, pancreatic cancer, drug repurposing
- MeSH terms
- Angiotensins, Animals, Antineoplastic Agents, Collagen, Drug Synergism, Female, Fluorouracil, Humans, Hyaluronic Acid, Mammary Neoplasms, Experimental, Pancreatic Neoplasms, Stress, Mechanical, Cell Hypoxia, Gene Expression Regulation, Neoplastic, Stromal Cells, Endothelin-1, Losartan, Mechanotransduction, Cellular, Receptor, Angiotensin, Type 1, Angiotensin II Type 1 Receptor Blockers, Mice, Transforming Growth Factor beta1, Connective Tissue Growth Factor, Drug Repositioning
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.